Your browser doesn't support javascript.
loading
Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial.
Heise, Tim; Mari, Andrea; DeVries, J Hans; Urva, Shweta; Li, Jing; Pratt, Edward John; Coskun, Tamer; Thomas, Melissa K; Mather, Kieren J; Haupt, Axel; Milicevic, Zvonko.
Affiliation
  • Heise T; Profil, Neuss, Germany.
  • Mari A; Institute of Neuroscience, National Research Council, Padova, Italy.
  • DeVries JH; Profil, Neuss, Germany.
  • Urva S; Eli Lilly, Indianapolis, IN, USA.
  • Li J; Eli Lilly, Indianapolis, IN, USA.
  • Pratt EJ; Eli Lilly, Indianapolis, IN, USA.
  • Coskun T; Eli Lilly, Indianapolis, IN, USA.
  • Thomas MK; Eli Lilly, Indianapolis, IN, USA.
  • Mather KJ; Eli Lilly, Indianapolis, IN, USA.
  • Haupt A; Eli Lilly, Indianapolis, IN, USA.
  • Milicevic Z; Eli Lilly, Indianapolis, IN, USA. Electronic address: milicevic_zvonko@lilly.com.
Lancet Diabetes Endocrinol ; 10(6): 418-429, 2022 06.
Article in En | MEDLINE | ID: mdl-35468322

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Insulin Resistance / Islets of Langerhans / Diabetes Mellitus, Type 2 / Insulins Type of study: Clinical_trials / Diagnostic_studies Limits: Adult / Humans Language: En Journal: Lancet Diabetes Endocrinol Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Insulin Resistance / Islets of Langerhans / Diabetes Mellitus, Type 2 / Insulins Type of study: Clinical_trials / Diagnostic_studies Limits: Adult / Humans Language: En Journal: Lancet Diabetes Endocrinol Year: 2022 Document type: Article Affiliation country: Country of publication: